Home  >  News
you can get e-magazine links on WhatsApp.Click here
+ Font Resize -

Centre approves 19 applications for domestic manufacturing of APIs, key drug intermediates under PLI scheme

Our Bureau, Mumbai
Saturday, February 27, 2021, 16:45 Hrs  [IST]

The central government has approved 19 applications with committed investment of Rs 4,623.01 crore under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical key drug intermediates and active pharmaceutical ingredients (APIs).

The Department of Pharmaceuticals had launched a Production Linked Incentive (PLI) Scheme for promotion of their domestic manufacturing by setting up greenfield plants with minimum domestic value addition in four different target segments (In Two Fermentation based - at least 90% and in the Two Chemical Synthesis based – at least 70% ) with a total outlay of Rs. 6,940 crore. for the period 2020-21 to 2029-30.

“The applications under four different target Segments were invited with 30th November, 2020 as the last date. In total, 215 applications have been received for the 36 products spread across the 4 Target Segments,” the ministry said.

The guidelines prescribed that the applications would be processed and decided within a period of 90 days, i.e., up to February 28th, 2021. Five applications with a committed investment of Rs.3,761crore have already been approved under Target Segment I.

The eligible firms and the products they will manufacture are Natural Biogenex Private Limited (Betamethasone, Dexamethasone, Prednisolone), SymbiotecPharmalab Private Limited (Prednisolone), Macleods Pharmaceutical Limited (Rifampicin), Optimus Drugs Private Limited (Streptomycin), Sudarshan Pharma Industries Limited (Vitamin B1), Saraca Laboratories Limited (1,1 Cyclohexane Diacetic Acid), Emmennar Pharma Private Limited (1,1 Cyclohexane Diacetic Acid), Hindys Lab Private Limited (1,1 Cyclohexane Diacetic Acid), Aarti Speciality Chemicals Limited (2-Methyl-5NitroImidazole ), Meghmani LLP (Para amino phenol) and Sadhana Nitro Chem Limited (Para amino phenol).

The ministry said that setting up of these plants will lead to total committed investment of Rs 862.01crore by the companies and employment generation of about 1763.

The commercial production is projected to commence from April 1st, 2023 onwards and the disbursal of production linked incentive by the Government over the six years period would be up to a maximum of Rs.4,870 crore.


Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |